Robitussin AC

Common Uses

This medication is used to treat symptoms associated with the common cold and other upper respiratory tract infections. It contains two active ingredients that work together to manage a productive cough:

• Cough Suppression: It contains a medicine that helps reduce the urge to cough by affecting the cough center in the brain.
• Expectorant Action: It contains an ingredient that helps thin and loosen mucus in the airways, making it easier to clear the chest through coughing.

Robitussin AC is typically used when a cough is accompanied by chest congestion and the presence of thick mucus. It helps make a cough more productive while also reducing the frequency of coughing fits.

Conditions Treated

Healthcare providers may prescribe this medication for the temporary relief of symptoms caused by:

• The common cold
• The flu (influenza)
• Bronchitis
• Other breathing illnesses that involve both a cough and mucus production

This medication is intended to manage symptoms but does not treat the underlying cause of the illness, such as a virus or bacteria. It is generally not used for chronic coughs caused by smoking, asthma, or emphysema unless specifically directed by a doctor.

How the Ingredients Work

Robitussin AC is a combination medication used to treat cough and congestion. It contains two primary components that target different aspects of a cough:

• Codeine: This is an opioid antitussive, or cough suppressant. It works by decreasing activity in the part of the brain that causes coughing, thereby reducing the urge to cough.
• Guaifenesin: This is an expectorant. It works by thinning the mucus and secretions in the air passages. This makes the mucus less sticky and easier to clear from the chest when you do cough.

By using these two mechanisms, the medication helps to quiet a cough while also making the coughs you do have more productive at clearing out phlegm.

Common Side Effects

Some people may experience mild side effects while taking this medication. These often include:

• Dizziness or lightheadedness
• Drowsiness
• Nausea or vomiting
• Stomach pain
• Constipation
• Headache
• Sweating

Serious Side Effects

Contact a healthcare provider immediately or seek emergency medical care if you experience any of the following serious symptoms:

• Slow, shallow, or difficult breathing
• Extreme drowsiness or difficulty waking up
• Confusion or hallucinations
• Fainting or severe dizziness
• Fast, pounding, or irregular heartbeat
• Seizures
• Signs of a severe allergic reaction, such as a skin rash, hives, itching, or swelling of the face, tongue, or throat

Boxed Warnings

Robitussin AC contains codeine, an opioid that exposes users to the risks of addiction, abuse, and misuse, which can lead to overdose and death. Serious, life-threatening, or fatal respiratory depression may occur. The risk is highest when starting the medication or following a dose increase. Accidental ingestion of even one dose, especially by children, can result in a fatal overdose.

Age Restrictions and Contraindications

• Children under 12: This medication is contraindicated in all children younger than 12 years of age due to the risk of fatal respiratory depression.
• Post-Surgical Use: It is contraindicated for pain or cough management in children younger than 18 years of age following tonsillectomy or adenoidectomy.
• Adolescents: Use is not recommended in adolescents aged 12 to 18 who have other risk factors that may increase sensitivity to the respiratory depressant effects of codeine, such as obstructive sleep apnea, obesity, or severe lung disease.

Interactions and Metabolism Risks

Using Robitussin AC with benzodiazepines, alcohol, or other central nervous system depressants may result in profound sedation, respiratory distress, coma, and death. Additionally, some individuals are ultra-rapid metabolizers of codeine. This genetic variation causes the liver to convert codeine into morphine more rapidly and completely than usual, which can lead to life-threatening respiratory depression even at prescribed doses.

Pregnancy and Breastfeeding

Prolonged use of opioid-containing medications during pregnancy can cause neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated. Because of the potential for serious adverse reactions in nursing infants, including excess sleepiness and difficulty breathing, breastfeeding is not recommended while taking this medication.

Other Medical Precautions

• Head Injury: The respiratory depressant effects of opioids and the capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury or other intracranial lesions.
• Gastrointestinal Conditions: Codeine may obscure the diagnosis or clinical course of patients with acute abdominal conditions and is contraindicated in patients with known or suspected gastrointestinal obstruction, including paralytic ileus.
• Existing Lung Disease: Caution is advised for individuals with asthma, COPD, or other breathing disorders, as the medication can further decrease the drive to breathe.

Pregnancy

Robitussin AC contains codeine, which is an opioid medication. Using opioid medications for a prolonged period during pregnancy may cause the baby to experience withdrawal symptoms after birth, a condition known as neonatal opioid withdrawal syndrome. This condition can be life-threatening if not recognized and treated. It is important to discuss the risks and benefits with a healthcare provider if you are pregnant or planning to become pregnant.

Breastfeeding

The codeine in Robitussin AC passes into breast milk and is converted into morphine by the body. Some individuals process codeine much faster and more completely than others, which can result in higher-than-expected levels of morphine in breast milk. This poses a serious risk to a nursing infant, potentially causing:

• Extreme sleepiness or difficulty waking up
• Difficulty breastfeeding
• Limpness
• Serious breathing problems

Due to these risks, healthcare providers generally advise against using products containing codeine while breastfeeding. If you are nursing, consult your doctor to discuss safer alternatives for managing cough symptoms.

Available Forms

Robitussin AC is available in the following form:

• Oral Liquid: This medication is a syrup intended to be taken by mouth.

FDA Approval and Classification

Robitussin AC is approved by the FDA for the temporary relief of cough and chest congestion associated with the common cold or other upper respiratory conditions. Because it contains codeine, an opioid, it is regulated as a Schedule V controlled substance. This classification indicates that while the medication has an accepted medical use, it carries a potential for abuse and dependence.

Safety Restrictions and Contraindications

The FDA has issued several safety communications regarding codeine-containing products. These medications are strictly contraindicated in children under the age of 12. Additionally, the FDA recommends against their use in adolescents between 12 and 18 years of age who have risk factors that increase their sensitivity to the respiratory depressant effects of codeine, such as obesity, obstructive sleep apnea, or chronic lung disease. The FDA also recommends against the use of codeine-containing medicines while breastfeeding due to the risk of serious adverse reactions in infants.

Boxed Warnings

Robitussin AC carries boxed warnings, the FDA’s most serious type of warning, due to the risks associated with codeine. These warnings include:

• Addiction, Abuse, and Misuse: Use of codeine can lead to opioid use disorder and overdose.
• Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal breathing problems may occur.
• Ultra-Rapid Metabolism: Some individuals possess a genetic variation that causes them to metabolize codeine into morphine much faster than normal, which can lead to life-threatening respiratory depression even at standard doses.
• Interactions with Other Drugs: Using this medication with benzodiazepines or other central nervous system depressants can result in profound sedation, respiratory depression, coma, and death.

How this cough syrup works

Robitussin AC contains two active ingredients that work together to manage symptoms. Codeine is an opioid cough suppressant that acts on the brain to reduce the urge to cough. Guaifenesin is an expectorant that helps thin and loosen mucus in the airways, making it easier to clear chest congestion through coughing.

Proper use and administration

This medication is a liquid syrup intended for oral use. Because it contains codeine, it is important to follow these safety guidelines:

• Use a medical measuring device rather than a household spoon to ensure the correct dose.
• Do not take more of the syrup than prescribed, as codeine can be habit-forming.
• This syrup is generally intended for short-term use to manage acute symptoms.

Important considerations

As a cough syrup containing an opioid, Robitussin AC may cause drowsiness, dizziness, or constipation. It should not be used for chronic coughs caused by smoking, asthma, or emphysema unless directed by a healthcare provider. It is also not recommended for use in children under a certain age due to the risk of serious breathing problems.